YISHENG PHARM: Plans to use no more than 100 million yuan of idle self-owned funds to purchase financial products

YISHENG PHARM announced that the company will hold a board of directors and supervisory board meeting on March 10, 2025, to review and approve the proposal to use no more than 100 million yuan of idle self-owned funds to purchase wealth management products. The investment period is 12 months, and the funds can be used on a rolling basis. The wealth management products include stable products issued by financial institutions such as banks, brokerages, and asset management companies